Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1Intracranial Germ Cell CNS Tumor, Childhood 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

Ifosfamide 6Paclitaxel 5Filgrastim 5Carboplatin 5Etoposide 4Cisplatin 4pegfilgrastim 3Granulocyte Colony-Stimulating Factor 3Thiotepa 2Mesna 2Brentuximab Vedotin 2Bleomycin 2sargramostim 1pegylated granulocyte colony-stimulating factor 1ixabepilone 1etoposide phosphate 1aldesleukin 1Vincristine 1Therapeutics 1Taxes 1Sunitinib 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Interleukin-11 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Embryonal × Second-Look Surgery × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡